Nitazoxanide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1098 publications
Efficacy of combined atorvastatin and paromomycin in treating experimental cryptosporidiosis in immunosuppressed mice.
Journal: QJM : monthly journal of the Association of Physicians
Published: September 03, 2026
Integrated Phytochemical, Computational and In Vitro Evaluation of the Oocysticidal Activity of Pleurotus ostreatus Extract Against Cryptosporidium parvum.
Journal: Cell biochemistry and biophysics
Published: July 17, 2026
Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657].
Journal: Toxicology and applied pharmacology
Published: July 02, 2026
Repurposing nitazoxanide as a novel ferroptosis inducer for triple-negative breast cancer via dual disruption of iron homeostasis and the β-catenin/GPX4 axis.
Journal: Redox report : communications in free radical research
Published: June 29, 2026
Fascioliasis presenting as non-resolving liver abscess: Case series from eastern India.
Journal: Tropical doctor
Published: May 30, 2026
Sapovirus Infection in Kidney Transplant Recipients: A Case Series Demonstrating the Burden of an Enteric Viral Pathogen.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: May 26, 2026
Nitazoxanide activates BMP9-ALK1-SMAD signaling cascade and improves HHT vascular pathology.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
In silico study: ADMET-driven pharmacokinetic profiling of antiviral compounds for pre-clinical screening framework of intranasal drug development.
Journal: Journal of pharmacological and toxicological methods
Published: May 08, 2026
Azithromycin Mitigates Experimental Cryptosporidiosis-Driven Ileocecal Adenocarcinoma by Modulating Autophagy, Apoptosis, and PI3K/AKT Signaling.
Journal: Biomedicines
Published: April 12, 2026
Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236.
Journal: Biomolecules
Published: April 10, 2026
Terpene-Enriched Nitazoxanide-Loaded Chondrosomes: Aerodynamic Characterization and In Silico Evaluation of Antiviral Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 24, 2026
Last Updated: 09/26/2026